Your browser doesn't support javascript.
loading
EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian, Mehdi; Nissinen, Liisa; Siljamäki, Elina; Riihilä, Pilvi; Toriseva, Mervi; Kivisaari, Atte; Ala-Aho, Risto; Kallajoki, Markku; Veräjänkorva, Esko; Honkanen, Hanne-Kaisa; Heljasvaara, Ritva; Pihlajaniemi, Taina; Grénman, Reidar; Peltonen, Juha; Peltonen, Sirkku; Kähäri, Veli-Matti.
  • Farshchian M; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Nissinen L; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Siljamäki E; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Riihilä P; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Toriseva M; Department of Cell Biology and Anatomy, University of Turku, Turku, Finland.
  • Kivisaari A; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Ala-Aho R; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Kallajoki M; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
  • Veräjänkorva E; Department of Plastic and General Surgery, University of Turku and Turku University Hospital, Turku, Finland.
  • Honkanen HK; Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
  • Heljasvaara R; Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
  • Pihlajaniemi T; Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
  • Grénman R; Department of Otorhinolaryngology, Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland.
  • Peltonen J; Department of Cell Biology and Anatomy, University of Turku, Turku, Finland.
  • Peltonen S; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.
  • Kähäri VM; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland. Electronic address: veli-matti.kahari@utu.fi.
J Invest Dermatol ; 135(7): 1882-1892, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25789706
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / ARN Mensajero / Carcinoma de Células Escamosas / Regulación Neoplásica de la Expresión Génica / Receptor EphB2 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / ARN Mensajero / Carcinoma de Células Escamosas / Regulación Neoplásica de la Expresión Génica / Receptor EphB2 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2015 Tipo del documento: Article